Patent No. EP4549579 (titled "Composition And Method For Evaluating Responsiveness Of Edaravone") was filed by Mitsubishi Tanabe Pharma on Jun 30, 2023. The application was issued on May 7, 2025.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents